| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.9 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |